Will Puma Biotechnology Break Out of Its Rut in 2020?
Stocktwits on Twitter: "Puma Biotechnology is tanking after-hours, down over -30% on the likelihood it won't get approval from European agency for its cancer drug. https://t.co/To0cg7EEgW $PBYI… https://t.co/AzItQ6mq2R"